Citation Impact
Citing Papers
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
2017 Standout
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Breast cancer
2019 Standout
Immunotherapy and targeted therapy combinations in metastatic breast cancer
2019
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Breast cancer statistics, 2019
2019 Standout
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
2022 StandoutNobel
Immune Checkpoint Blockade for Breast Cancer
2018
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression
2018
Hepatocellular carcinoma
2021 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry
2017
Underlying mechanisms and drug intervention strategies for the tumour microenvironment
2021
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Tertiary lymphoid structures in the era of cancer immunotherapy
2019
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
2017
Immunotherapy for Breast Cancer: Current and Future Strategies
2017
Gastric cancer
2020 Standout
DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy
2018
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
2019
The molecular landscape of head and neck cancer
2018 Standout
Implications of the tumor immune microenvironment for staging and therapeutics
2017
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Tumor-infiltrating lymphocytes in breast cancer according to tumor subtype: Current state of the art
2017
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
2016
Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB
2017
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Works of Nathan Cuka being referenced
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
2016
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
2015